Liyi Zhang

State Key Laboratory Of Oncology In South China
Guangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

E2112-Does a negative phase III trial of endocrine therapy plus histone deacetylase inhibitor in hormone receptor-positive advanced breast cancer represent a death knell?

E2112-Does a negative phase III trial of endocrine therapy plus histone deacetylase inhibitor in hormone receptor-positive advanced breast cancer represent a death knell?

Journal: Thoracic cancer

Published: March 07, 2022

Single-Cell Profiling Explore the Immunologic Mechanisms of Tumor Relapse in Hepatocellular Carcinoma.

Single-Cell Profiling Explore the Immunologic Mechanisms of Tumor Relapse in Hepatocellular Carcinoma.

Journal: Global medical genetics

Published: August 25, 2021

Safety and Efficacy of Human Epidermal Growth Factor Receptor 2-Targeted Therapies in Advanced Breast Cancer: A Head-to-Head Comparison of Margetuximab versus Trastuzumab.

Safety and Efficacy of Human Epidermal Growth Factor Receptor 2-Targeted Therapies in Advanced Breast Cancer: A Head-to-Head Comparison of Margetuximab versus Trastuzumab.

Journal: Asia-Pacific journal of oncology nursing

Published: April 15, 2021

PERFECT trial results: Combining neoadjuvant chemoradiotherapy with atezolizumab is feasible in resectable esophageal adenocarcinoma.

PERFECT trial results: Combining neoadjuvant chemoradiotherapy with atezolizumab is feasible in resectable esophageal adenocarcinoma.

Journal: Thoracic cancer

Published: April 05, 2021

Oncogenic KRAS Drives Metabolic Vulnerabilities by Directly Regulating Metabolic Enzymes in Cancer.

Oncogenic KRAS Drives Metabolic Vulnerabilities by Directly Regulating Metabolic Enzymes in Cancer.

Journal: Global medical genetics

Published: September 04, 2020

Novel stimulation strategy with autologous tumor cells to generate T cell receptor-engineered T cells in esophageal squamous cell carcinoma.

Novel stimulation strategy with autologous tumor cells to generate T cell receptor-engineered T cells in esophageal squamous cell carcinoma.

Journal: Thoracic cancer

Published: March 02, 2020

Circular RNA: The main regulator of energy metabolic reprogramming in cancer cells.

Circular RNA: The main regulator of energy metabolic reprogramming in cancer cells.

Journal: Thoracic cancer

Published: October 24, 2019

Linking metabolic and epigenetic regulation in the development of lung cancer driven by TGFβ signaling.

Linking metabolic and epigenetic regulation in the development of lung cancer driven by TGFβ signaling.

Journal: AIMS genetics

Published: May 31, 2019

Showing 1-8 of 8

Last Updated: 09/26/2026